News

The safety and immunogenicity of a fourth dose of NVX-CoV2373

0
3D render of a medical background with DNA strands

Researchers assessed the immunogenicity and safety of a fourth homologous boost dose of a recombinant SARS-CoV-2 spike protein vaccine called NVX-CoV2373.

Germany vs Japan livestream options for 2022 FIFA World Cup

Previous article

‘An Arm and a Leg’: When insurance won’t pay, abortion assistance funds step in

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News